CN114828735A - 使用生物标记物分析用于个性化皮肤护理的系统和方法 - Google Patents
使用生物标记物分析用于个性化皮肤护理的系统和方法 Download PDFInfo
- Publication number
- CN114828735A CN114828735A CN202080062859.9A CN202080062859A CN114828735A CN 114828735 A CN114828735 A CN 114828735A CN 202080062859 A CN202080062859 A CN 202080062859A CN 114828735 A CN114828735 A CN 114828735A
- Authority
- CN
- China
- Prior art keywords
- skin
- care product
- skin care
- computing device
- concentration information
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B19/00—Programme-control systems
- G05B19/02—Programme-control systems electric
- G05B19/18—Numerical control [NC], i.e. automatically operating machines, in particular machine tools, e.g. in a manufacturing environment, so as to execute positioning, movement or co-ordinated operations by means of programme data in numerical form
- G05B19/414—Structure of the control system, e.g. common controller or multiprocessor systems, interface to servo, programmable interface controller
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0278—Product appraisal
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/06—Buying, selling or leasing transactions
- G06Q30/0601—Electronic shopping [e-shopping]
- G06Q30/0621—Item configuration or customization
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/06—Buying, selling or leasing transactions
- G06Q30/0601—Electronic shopping [e-shopping]
- G06Q30/0631—Item recommendations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B2219/00—Program-control systems
- G05B2219/30—Nc systems
- G05B2219/32—Operator till task planning
- G05B2219/32287—Medical, chemical, biological laboratory
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Business, Economics & Management (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Accounting & Taxation (AREA)
- Finance (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Strategic Management (AREA)
- Development Economics (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Theoretical Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Business, Economics & Management (AREA)
- Economics (AREA)
- Marketing (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Databases & Information Systems (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/528,380 US11741523B2 (en) | 2019-07-31 | 2019-07-31 | Personalized skincare recommendations based on biomarker analysis |
US16/528,196 US11501356B2 (en) | 2019-07-31 | 2019-07-31 | Systems and methods for generating personalized skincare formulations based on biomarker analysis |
US16/528,196 | 2019-07-31 | ||
US16/528,380 | 2019-07-31 | ||
PCT/US2020/042012 WO2021141634A2 (en) | 2019-07-31 | 2020-07-14 | Systems and methods for using biomarker analysis for personalized skincare |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114828735A true CN114828735A (zh) | 2022-07-29 |
Family
ID=75825823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080062859.9A Pending CN114828735A (zh) | 2019-07-31 | 2020-07-14 | 使用生物标记物分析用于个性化皮肤护理的系统和方法 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP4004932A2 (ja) |
JP (2) | JP7467594B2 (ja) |
KR (1) | KR20220038470A (ja) |
CN (1) | CN114828735A (ja) |
WO (1) | WO2021141634A2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023154557A1 (en) * | 2022-02-14 | 2023-08-17 | Washington University | Methods for detecting surgical drain fluid exosomes and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL157786A (en) | 2003-09-07 | 2010-11-30 | Ahava Dead Sea Lab Ltd | Personalized cosmetics |
SG10201505321RA (en) | 2007-01-05 | 2015-08-28 | Myskin Inc | System, device and method for dermal imaging |
FR2968560A1 (fr) * | 2010-12-13 | 2012-06-15 | Oreal | Utilisation de l'ide comme biomarqueur d'un etat du cuir chevelu |
JP6022260B2 (ja) | 2012-08-22 | 2016-11-09 | ロート製薬株式会社 | 皮膚状態の評価方法 |
CN112858654B (zh) | 2013-03-15 | 2024-05-24 | 宝洁公司 | 用于测量皮肤健康代谢物的非侵入性方法 |
JP7046095B2 (ja) | 2017-04-03 | 2022-04-01 | ロレアル | 化粧料組成物を形成するためのシステムおよびスキンケア管理システム |
-
2020
- 2020-07-14 EP EP20883687.4A patent/EP4004932A2/en active Pending
- 2020-07-14 CN CN202080062859.9A patent/CN114828735A/zh active Pending
- 2020-07-14 KR KR1020227006298A patent/KR20220038470A/ko unknown
- 2020-07-14 WO PCT/US2020/042012 patent/WO2021141634A2/en unknown
- 2020-07-14 JP JP2022506506A patent/JP7467594B2/ja active Active
-
2024
- 2024-04-03 JP JP2024060132A patent/JP2024081779A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4004932A2 (en) | 2022-06-01 |
JP2022542457A (ja) | 2022-10-03 |
WO2021141634A2 (en) | 2021-07-15 |
JP2024081779A (ja) | 2024-06-18 |
WO2021141634A3 (en) | 2021-09-16 |
KR20220038470A (ko) | 2022-03-28 |
JP7467594B2 (ja) | 2024-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11501856B2 (en) | Personalised nutrient dosing with on-going feedback loop | |
US11741523B2 (en) | Personalized skincare recommendations based on biomarker analysis | |
D’Souza et al. | Differences in the prevalence of human papillomavirus (HPV) in head and neck squamous cell cancers by sex, race, anatomic tumor site, and HPV detection method | |
US20230206300A1 (en) | Systems and methods for generating personalized skincare formulations based on biomarker analysis | |
JP2024081779A (ja) | パーソナライズスキンケアのためにバイオマーカー解析を使用するためのシステムおよび方法 | |
Whyte et al. | A confound-free test of the effects of thin-ideal media images on body satisfaction | |
JP2022523110A (ja) | バイオマーカー分析に基づいて将来の皮膚傾向を視覚化するためのシステムおよび方法 | |
Schop et al. | The effectiveness of a routine versus an extensive laboratory analysis in the diagnosis of anaemia in general practice | |
Maqsood et al. | Expression of CD34 and α-SMA markers in oral squamous cell carcinoma differentiation. A histological and histo-chemical study | |
US11049605B1 (en) | Computer-implemented systems and methods for generating tailored medical recipes for mental health disorders | |
Pieper et al. | Coordinate expression of cytokeratins 7 and 14, vimentin, and Bcl-2 in canine cutaneous epithelial tumors and cysts | |
Khan | Role of augmented reality in influencing purchase intention among millenials | |
CN110648730A (zh) | 用于识别受试者的健康状态的方法和系统 | |
Al Baghal et al. | Collection of biomarkers using nurses, interviewers, and participants: the design of IP12 | |
US20230043674A1 (en) | Scientific and technical systems and methods for providing hair health diagnosis, treatment, and styling recommendations | |
Rosetti et al. | A comparison of sexual arousal in men exposed to visual stimuli with and without facial blurring | |
US20200402128A1 (en) | Product identification using sensory input | |
Schulkey et al. | Design and implementation of the all of us research program COVID-19 Participant Experience (COPE) survey | |
EP3287917A1 (en) | Distributed data gathering and recommendation in phytotherapy | |
Lambert-Messerlian et al. | Measuring maternal serum screening markers for Down’s syndrome in plasma collected for cell-free DNA testing | |
Jones et al. | Analyzing the area under the curve of pharyngeal pH probes in the diagnosis of reflux disease | |
US11328346B2 (en) | Method, system, and computer program product for product identification using sensory input | |
WO2001043003A1 (fr) | Procede et systeme de communication d'avis medicaux | |
Šumak et al. | An empirical study of factors affecting the adoption of self-service checkout terminals in Slovenia | |
Iester et al. | Sector-based analysis of frequency doubling technology sensitivity and optic nerve head shape parameters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |